CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced that John Climaco, Chief Executive Officer of CNS Pharmaceuticals will participate in a fireside chat at the Healthcare Company Showcase hosted by Alliance Global Partners on May 21, 2024 at 1:40 PM ET.
A live webcast of the event will be on the Events page of the Investors section of the Company's website (cnspharma.com).
https://finance.yahoo.com/news/cns-pharmaceuticals-present-alliance-global-123000607.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.